Carotid Doppler Screening for Subclinical Atherosclerosis in Diabetic CKD Patients.
NCT ID: NCT07266220
Last Updated: 2025-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
96 participants
OBSERVATIONAL
2026-01-31
2027-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We will use a safe, non-invasive test called carotid Doppler ultrasound, which uses sound waves to check the neck arteries (carotid arteries) for early changes. The goal is to see how often these early changes occur in patients with diabetes and CKD, and whether the findings relate to their kidney function, blood sugar control, and other health factors.
This research may help doctors detect vascular problems earlier and guide better prevention strategies for patients at risk.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Possible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced Nephropathy
NCT04531163
Ameliorating Contrast Induced Nephropathy After Coronary Angiography
NCT06139952
Predictive Value of CHA2DS2VASC Score for Contrast-induced Nephropathy After Primary Percutaneous Coronary Intervention in ST-segment Elevation Myocardial Infarction Patients
NCT04730778
Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction
NCT01160627
Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes
NCT01978405
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Diagnosis of type 2 diabetes mellitus (per treating physician or ADA criteria).
3. CKDstage3:eGFR30-59mL/min/1.73 m² on at least two measurements ≥3 months apart OR established diagnosis in medical record.
4. Clinically stable (no AKI, no hospitalization for cardiovascular event in past 3 months).
5. Ableandwilling to provide informed consent.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abdallah Ali Mohammed
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abdallah Ali Mohammed
Resident Physician, Internal Medicine
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AUN-IM-CKD-CAROTID-2025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.